Engagement With Recommended Developmental Follow-up and Supports Among Infants With Intrauterine Opioid Exposure
Three-quarters of the OEI engaged in developmental surveillance services in the first year of life. Factors relating to disease severity, location of birthing parent care, birthing parent co-exposures, and parental custody were associated with engagement. Efforts to improve engagement in recommended follow-up should elicit the perspectives of caregivers to better understand the mechanisms that drive these differences.
Authors
- Yarden S. Fraiman (ORCID: https://orcid.org/0000-0002-9252-1721)
- Elizabeth Peacock‐Chambers (ORCID: https://orcid.org/0000-0002-8163-6662)
- Leslie S Kerzner
- Davida M. Schiff (ORCID: https://orcid.org/0000-0002-6435-1016)
- Margarida Mascarenhas (ORCID: https://orcid.org/0000-0002-1785-1202)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Massachusetts Chan Medical School (US)
- Jackson Memorial Hospital (US)
- MaineGeneral Medical Center (US)
- Baystate Health (US)
Publication Details
- Journal
- Journal of Developmental & Behavioral Pediatrics
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1097/dbp.0000000000001372
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute on Drug Abuse